IECM
CLMT icon

Intrinsic Edge Capital Management’s Calumet Specialty Products CLMT Stock Holding History

Intrinsic Edge Capital Management’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-250,000
Closed -$553K – 115
2018
Q4 		$553K Buy
+250,000
New +$1.03M 0.09% 105
2017
Q4 		– Sell
-50,000
Closed -$418K – 121
2017
Q3 		$418K Buy
+50,000
New +$312K 0.08% 107

Other funds holding CLMT

AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
SCM
SCW Capital Management Dallas, Texas $44M AUM 39.16% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
WWM
Windsor Wealth Management Indianapolis, Indiana $546M AUM 16.47% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
BC
Barnett & Company Chattanooga, Tennessee $135M AUM 27.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Intrinsic Edge Capital Management's CLMT Position: Q1 2019 in Review

Intrinsic Edge Capital Management sold out of Calumet Specialty Products (CLMT) in Q1 2019, closing a stake of 250,000 shares — an estimated $553K sold.

Intrinsic Edge Capital Management first reported a position in CLMT in Q3 2017 and held it in 2 quarters. The position peaked at $553K in Q4 2018. 70 funds tracked by Wall St. Rank hold CLMT as of Q1 2019.

  • Intrinsic Edge Capital Management reported no remaining Calumet Specialty Products position as of Q1 2019 after selling out during the quarter.
  • Intrinsic Edge Capital Management sold 250,000 Calumet Specialty Products shares in Q1 2019, an estimated $553K.
  • Intrinsic Edge Capital Management first reported a position in Calumet Specialty Products in Q3 2017 and held it in 2 quarters.
  • Intrinsic Edge Capital Management's Calumet Specialty Products position peaked at $553K in Q4 2018.
  • 70 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q1 2019.

Based on Intrinsic Edge Capital Management's 13F filing for Q1 2019, filed 14 May 2019.